U.S. Markets closed

Ganaxalone Faces Stiff Competition from Other Drugs under Development

Kenneth Smith

Marinus Pharmaceuticals (MRNS) has initiated a phase two study to test the feasibility of ganaxalone in patients suffering from refractory status epilepticus (or RSE). Data from this study is expected ...